Cannabics Pharmaceuticals ^Companies

Cannabics Pharmaceuticals is a U.S based company dedicated to the development of personalized anti-cancer treatments. Their scientific focus is on harnessing the therapeutic properties of natural cannabinoids to create tailored therapies for cancer patients. The company conducts research and development in Israel, where it is licensed by the Ministry of Health, and utilizes advanced screening systems and bioinformatic tools. They have pioneered the world's first cannabinoid-based antitumor drug candidate for the treatment of colorectal cancer and are proud to be a global leader in the development of cancer-related cannabinoid-molecule based therapeutic formulations and medicines.